Occlusion Devices Market Size was valued at USD 2.08 Billion in 2023. The Global Occlusion Devices industry is projected to grow from USD 2.18 Billion in 2024 to USD 2.43 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.90% during the forecast period (2024 - 2032).
The occlusion has been termed as a medical term that means a blockage or a closing of a blood vessel in a hollow organ. Here, there are different kinds of occlusion devices that have been preferred for treating different kinds of cardiovascular defects, retinal defects, and neurological defects as well.
Further, the occlusion devices market has mainly been driven high by the prevalence of the huge demand for treatment and diagnosis. Apart from that, increasing availability of diagnostic services includes the various chronic diseases treatment and it fuels up the growth of the market.
Hence, the favourable reimbursement of the policies has been likely to boost up the growth of the market. This mainly includes government insurance as well as private insurance that has been developed in the countries. The policies have been generated with more than 75% of the cost value of the treatment and the devices.
For instance, it states that under the medical plan, the average cost of the device has been approximate by the USD rate of 6,000. Whereas, alternative treatment methods have been adopted to treat a chronic disease within the limited forecast period.
Covid 19 Analysis
In order to take care of the covid analysis, the infected population attempts to demand the supply of the medical devices. The respiratory support devices have helped in analysing the market and that mainly includes the life-support machine, oxygen generator, and atomizer. Hence, the impact of covid 19 has processed a huge surge in the demand for medical supplies, and it states the protective equipment such as gloves, masks, and protective glasses.
Therefore, the manufacturers have the ability to capitalize on the increased demand for medical support devices for precautions. Thus, considering these factors, Covid-19 has expected to have a significant impact on the Occlusion devices market. Further, it has managed to anticipate the market effect as well as the regaining of the harmful situation after the lockdown days in the coming period.
PipelineTM Vantage, a fourth-generation flow diverter featuring Shield Technology, was launched by Medtronic PLC in June 2022 fully-owned subsidiary, India Medtronic Private Limited, for endovascular treatment of brain aneurysms. This Pipeline Vantage with Shield Technology is a new flow diverter that has improvements in the design features of both the delivery system and implant.
Solus Gold Embolization Device, produced by Artio Medical Inc., was approved in March 2022 by the American FDA as a peripheral vascular occlusion next-generation therapy. Artio Medical Inc. is a medical device company that develops state-of-the-art solutions for the industry of peripheral vascular, neurovascular and cardiology.
Front Line Medical Technologies announced COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) availability and distribution in February 2022, which holds back aortic pressure to permissive hypotension in bleeding areas below the balloon, thus reducing chances of hemorrhage. It is the smallest lifesaving hemorrhage-controlling device.
In July 2021 Terumo Medical Corporation (TMC) announced that it had introduced AZUR Vascular Plug—the only plug compatible with microcatheter occluding arteries up to 8mm in diameter.
Boston Scientific’s Watchman FLX Left Atrial Appendage Closure (LAAC) Device—a second generation—was authorized by FDA—The United States Food and Drug Administration on July 22nd, 2020. The target population for Watchman FLX includes patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy other than stroke as this left atrial appendage closing product permanently seals off NVAF’s stroke-causing blood clot epicenter within the heart.
BD Peripheral Intervention has confirmed FDA approval for arterial Caterpillar and embolization devices in February 2020. The oncology field is gaining significant momentum in the market for occlusion devices. The use of occlusion devices in oncology is crucial for preventing blood loss during procedures by way of liquid embolic penetration.
The market drivers attempt to portray that the factors that involve the growing awareness also intend to state of the people have managed to benefit the devices by replacing the process over the life treatment devices. These devices have attempted to state that the rapid rise in the growth of medical procedures has been affected. Apart from that, the demand for minimal facilities of medical devices along with the global occlusion device of the market growth has been affected.
One of the major factors of restraints states that the high cost of the devices, technical challenges, regulatory requirements, and the situations faced by the surgeons. Hence, it attempts to showcase that the importance of the occlusion devices along with the lack of uniform reimbursement of the policies has been hampered. This has affected the demand of the occlusion devices market.
In this concise market of opportunities, it has been addressed that the increase in the spending on research and development has been considered to be an aggressive strategy. Apart from that, within this stated market, the opportunity of acquiring by the top market players for enhancing the growth of the market has been idealized as well. Therefore, the occlusion devices have been referred to as the basic structure that provides an ailment to the body of a human for better analysis. Hence, the implant of the device and the aid of retaining addresses to be flexible and its movement has been rapid growth with the market.
One of the basic challenging factors addressed states that this occlusion devices market has been addressed and it cumulates that the lack of occlusion devices has been addressed as well. This suggests the importance of the treatment has been lacking and it is indulged more for reimbursing the situation. Apart from that, another challenging factor has been addressed and it claims that the high cost of the medical structures and has been harsh for many people to afford. Hence, this factor has affected the growth of the market global market and has been addressed to be affected worldwide.
Value Chain Analysis
An increasing emphasis on creating diagnostic treatment facilities and has given a rise in the market. Hence, this has contributed to the overall impact on the market positively. Also, the growing initiatives by the government for the development and research will improve the value chain of the Occlusion Devices Market in the upcoming years.
Apart from that, the growth has been witnessed by the occlusion market and it is driven by the target population. The market has been segmented on the basis of application, product, and end-user. These stages that on the basis of product, the market has segmented into embolization devices, support devices, and occlusion removal devices. Further, the embolization devices have been segmented under the liquid embolic agents and the tubal occlusion systems.
Apart from that, the occlusion removal system has been sub-segmented into stent retrievers, coil retrievers, balloon occlusion devices, and the suction of aspiration devices. Therefore, the support device has been sub-segmented into the microcatheters and guidewires. Based on application, the market has been segmented into cardiology, peripheral vascular disease, urology, oncology, gynaecology, and many more. Lastly, based on end-user, the market is segmented into hospitals, clinics, diagnostic centres, and others.
Occlusion Devices Market Regional Analysis
According to the market segmentation of the region, the occlusion devices market has been segmented into two regions. North America has been segmented into two regions, North America and South America. Further, it has been addressed that being the largest market, the main driving point refers to the increasing population of a patient suffering from chronic diseases.
On the other hand, the growth in the investment within healthcare, an increase in the geriatric population has been analysed. Apart from that, the US has been considered as the largest market residing in North America and Canada is considered to be the fastest-growing market. This market appears to drive the overall demand for medical devices with progress within the occlusion system. Whereas, an increase in South America stages to state that an expectation has to be driven by the overall demand in the increasing progress.
The European device market exhibits to have positive growth and that tends to increase the emphasis on the diagnosis of chronic diseases. Henceforth, Germany and UK have been the major contributors to accelerating the growth of the market.
Occlusion Devices Market Competitive Landscape
The occlusion devices market comprises moderate competition and it initiates the importance of the several major players that competes with the market. Hence, some of the major key players are:
Recent Development
Report Overview
This report mainly includes all the details and it tends to initialize growth along with the better efficiency of the companies with particular management. It states that the driving factors have been interrupted due to the covid 19 situation. The entire analysis is based upon the Covid 19 analysis, regional analysis, market overview, segmentation analysis, market dynamics and it mainly includes the challenges, opportunities, restraints, and drivers.
Further, the competitive landscape and the other sections are been presented. Hence, all of the information, that has been collected is from the primary as well as the secondary sources.
By Geographically
| Report Attribute/Metric | Details |
| Market Size 2032 | USD 2.43 Billion |
| Compound Annual Growth Rate (CAGR) | 8.90% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2021 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Application & End-User |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Cardinal Health, Cook Group, Edwards Lifesciences, Abbott Laboratories, Acrostak, MicroPort Scientific Corporation, Vascular Concepts, Elixir Medical Corporation, Kyoto Medical Planning,Terumo Corporation |
| Key Market Opportunities | Growing prevalence of cardiovascular diseases globally, leading to increased demand for occlusion devices. |
| Key Market Dynamics | Increasing preference for minimally invasive procedures over traditional surgeries, boosting demand for occlusion devices. |
Frequently Asked Questions (FAQ) :
Global occlusion devices market is expected to expand at 8.90% CAGR from 2024 to 2032.
High prevalence of heart diseases and huge demand for its diagnosis are primary drivers of the global occlusion devices market.
Alternative treatment methods is the major factor expected to impede the global occlusion devices market growth.
APAC can showcase a robust CAGR in the global occlusion devices market till 2032 due to increasing focus on early detection of heart diseases.
Kyoto Medical Planning Co. Ltd., Translumina GmbH, Elixir Medical Corporation, Abbott Laboratories, Acrostak, Terumo Corporation, Stryker Corporation, Penumbra, Asahi Intecc, Edwards Lifesciences, Biosensors International Group, Ltd., Medtronic plc, Vascular Concepts, B. Braun Melsungen AG, Terumo Corporation, Cardinal Health, Avinger, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, Cook Group, and Angiodynamics are prominent players of the global occlusion devices market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
